This is a preview of subscription content, log in via an institution to check access.
Reference
Ahn CS, et al. Cost Effectiveness of Biologic Therapies for Plaque Psoriasis. American Journal of Clinical Dermatology : 22 May 2013. Available from: URL: http://dx.doi.org/10.1007/s40257-013-0030-z
Additional information
* The study was supported by Galderma Laboratories, L.P.
** a 75% improvement in the Psoriasis Area Severity Index
*** minimally important difference in the Dermatology Life Quality Index
Rights and permissions
About this article
Cite this article
Infliximab best choice in plaque psoriasis. PharmacoEcon Outcomes News 680, 12 (2013). https://doi.org/10.1007/s40274-013-0482-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0482-7